Undtagelsesvist kan vaccinen injiceres subkutant hos patienter med thrombocytopeni (nedsat antal blodplader) eller risiko for blødning.
Exceptionally, the vaccine may be administered subcutaneously in patients with thrombocytopoenia (diminution of blood platelets) or to persons at risk of haemorrhage.